Your browser doesn't support javascript.
loading
Outcomes of the European Federation of Pharmaceutical Industries and Associations Oligonucleotide Working Group Survey on Nonclinical Practices and Regulatory Expectations for Therapeutic Oligonucleotide Safety Assessment.
Tessier, Yann; Achanzar, William; Mihalcik, Lauren; Amuzie, Chidozie; Andersson, Patrik; Parry, Joel D; Moggs, Jonathan; Whiteley, Laurence O.
Afiliação
  • Tessier Y; Pharmaceutical Sciences, Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Achanzar W; Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, New Jersey, USA.
  • Mihalcik L; Amgen Research, Translational Safety & Bioanalytical Sciences, South San Francisco, California, USA.
  • Amuzie C; Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania, USA.
  • Andersson P; Respiratory and Immunology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Parry JD; Nonclinical Safety, GSK R&D, David Jack Centre for R&D, Ware, United Kingdom.
  • Moggs J; Preclinical Safety, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Whiteley LO; Pfizer Drug Safety Research and Development, Cambridge, Massachusetts, USA.
Nucleic Acid Ther ; 31(1): 7-20, 2021 02.
Article em En | MEDLINE | ID: mdl-33054599
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / Terapia Genética / Avaliação Pré-Clínica de Medicamentos Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Nucleic Acid Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / Terapia Genética / Avaliação Pré-Clínica de Medicamentos Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Nucleic Acid Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça